Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and cefdinir

erythromycin has been researched along with cefdinir in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Blandino, G; Caccamo, F; Di Marco, R; Nicoletti, A; Nicoletti, G; Speciale, A1
Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA1
Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A1
Hijioka, S; Inoue, S; Kugo, Y; Nishimura, T; Oguni, T; Sugiki, M; Sugita, K; Uemura, T; Wakamiya, E; Yoshikawa, K1
Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K1

Reviews

1 review(s) available for erythromycin and cefdinir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for erythromycin and cefdinir

ArticleYear
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae

2009
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens.
    Drugs under experimental and clinical research, 1992, Volume: 18, Issue:8

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefdinir; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Kinetics; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination

1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
    Journal of clinical microbiology, 1992, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin

1992
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Journal of chemotherapy (Florence, Italy), 1996, Volume: 8, Issue:3

    Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship

1996
[Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from the patients with respiratory tract infections in Hokusetsu Area of Osaka].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:7

    Topics: Anti-Bacterial Agents; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clindamycin; Erythromycin; Humans; Minocycline; Penicillin G; Penicillins; Respiratory Tract Infections; Serotyping; Streptococcus pneumoniae

2000
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus

2000